Geneva Bioinformatics (GeneBio) S.A. today announced the signing of a multi-year partnership agreement with Bruker Daltonics focused on GeneBio’s latest product release, Phenyx, the state-of-the-art protein identification platform. According to the agreement, Bruker Daltonics will incorporate Phenyx into its software portfolio and distribute globally a version of the platform specifically optimized for Bruker Daltonics’ mass spectrometers.
GeneBio’s Phenyx is a software platform for the identification and characterization of proteins and peptides from mass spectrometry data. Developed by GeneBio in collaboration with the Swiss Institute of Bioinformatics (SIB) and incorporating the true probabilistic and flexible scoring system OLAV, Phenyx is specifically designed to meet the concurrent demands of high-throughput mass spectrometry data analysis and dynamic high quality results assessment. End-users performing proteomics analysis can benefit from Phenyx’s many features, including tailored scoring for specific mass spectrometers as well as end users’ MS experimental set-ups, solid architecture available in multiple environments and inherent database access to support complex workflows, thereby maximizing the pertinence of their protein analysis.
“This collaboration continues a relationship that stretches back several years with another of our products,” said Nasri Nahas, CEO of GeneBio. “This collaboration with one of the market leaders in the field of mass spectrometry instrumentation is a sign of our continued commitment to provide scientists with unparalleled bioinformatics solutions for their proteomics research. Bruker Daltonics’ confidence in Phenyx is due to both the expertise of GeneBio and the capabilities of the product itself. We expect Phenyx to have a great impact on the proteomics market in the months and years to come.”
Per the agreement, GeneBio and Bruker Daltonics will also collaborate to enhance Phenyx’s functionality and further optimize the platform for a diverse array of Bruker Daltonics’ mass spectrometers and workflows. Bruker Daltonics will offer Phenyx as an option in its ProteinScapeä software platform in order to help proteomics customers achieve an even greater level of accuracy and success. This reflects both companies’ desire to give customers the ability to access the best solutions for their needs.
“We want our customers to have the best possible software tools available when they use our MS instruments,” said Dr. Herbert Thiele, Director of Bioinformatics of Bruker Daltonics. “Phenyx was tested on different Bruker Daltonics mass spectrometers and in different experimental set-ups, and was shown to be both reliable and accurate under diverse situations; we were very pleased with the results. The integration of Phenyx offers a software platform optimized for our systems, thereby allowing our Phenyx customers the accurate and pertinent results they expect from a leader in mass spectrometry.”
About GeneBio
Founded in 1997, GeneBio is a multifaceted bioinformatics company situated at the heart of the Lake Geneva Region, one of the world’s major proteomics centres of excellence. Based on expertise in the proteomics and bioinformatics fields, GeneBio offers original educational and knowledge-discovery solutions that help clients shape heterogeneous information into relevant biological knowledge.
For more information about GeneBio and Phenyx, please go to the following link:
Official site of GeneBio:www.genebio.com
Source: press release by GeneBio on February 3rd, 2005
Date of publication on this website: February 3rd, 2005
